Increased severity of stroke in CB1 cannabinoid receptor knock-out mice

Journal of Neuroscience

Volumn 22, Issue 22, 2002, Pages 9771-9775

  Parmentier Batteur, Sophie ^a   Jin, Kunlin ^a   Mao, Xiao Ou ^a   Xie, Lin ^a   Greenberg, David A ^a,b  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cannabinoid; CB1; Cerebral blood flow; Ischemia; NMDA; Receptor; Stroke

Indexed keywords

CANNABINOID 1 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BRAIN BLOOD FLOW; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; DISEASE SEVERITY; MALE; MORTALITY; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; SIGNAL TRANSDUCTION; STROKE;

EID: 0037111836     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-22-09771.2002     Document Type: Article

References (27)

1. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986a) Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17:472-476.
2. Bederson JB, Pitts LH, Germano IM, Nishimura MC, Davis RL, Bartkowski HM (1986b) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304-1307.
3. Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155-163.
4. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
5. Dietrich WD, Alonso O, Halley M, Busto R, Globus MY (1992) Intraventricular infusion of N-methyl-D-aspartate. I. Acute blood-brain barrier consequences. Acta Neuropathol (Berl) 84:621-629.
6. Gaoni Y, Mechoulam R (1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646-1647.
7. 2+ channel current. Am J Physiol 276:H2085-H2093.
8. Globus MY, Prado R, Sanchez-Ramos J, Zhao W, Dietrich WD, Busto R, Ginsberg MD (1995) A dual role for nitric oxide in NMDA-mediated toxicity in vivo. J Cereb Blood Flow Metab 15:904-913.
9. Hampson AJ, Grimaldi M, Axelrod J, Wink D (1998) Cannabidiol and (-)Δ9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95:8268-8273.
10. Hillard CJ (2000) Endocannabinoids and vascular function. J Pharmacol Exp Ther 294:27-32.
11. Iadecola C, Sugimoto K, Niwa K, Kazama K, Ross ME (2001) Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice. J Cereb Blood Flow Metab 21:1436-1441.
12. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G (1999) Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 96:14136-14141.
13. Jin KL, Mao XO, Goldsmith PC, Greenberg DA (2000) CB1 cannabinoid receptor induction in experimental stroke. Ann Neurol 48:257-261.
14. Ledent C, Valverde O, Cossu G, Petitet F, Aubert J-F, Beslot F, Böhme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283:401-404.
15. Lin TN, He YY, Wu G, Khan M, Hsu CY (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24:117-121.
16. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
17. Nagayama T, Sinor AD, Simon RP, Chen J, Graham S, Jin K, Greenberg DA (1999) Cannabinoids and neuroprotection from global and focal cerebral ischemia and in vitro. J Neurosci 19:2987-2995.
18. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413:527-531.
19. Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129-180.
20. Sharp FR, Lu A, Tang Y, Millhorn DE (2000) Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab 20:1011-1032.
21. Shen M, Thayer SA (1998) Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol 54:459-462.
22. Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334.
23. Simon RP, Swan JH, Griffiths T, Meldrum BS (1984) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226:850-852.
24. Sinor AD, Irvin SM, Greenberg DA (2000) Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett 278:157-160.
25. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778.
26. Sun Y, Jin K, Mao XO, Zhu Y, Greenberg DA (2001) Neuroglobin is upregulated by and protects neurons from hypoxic-ischemic injury. Proc Natl Acad Sci USA 98:15306-15311.
27. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H (1994) Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25:165-170.